Table 1 Frequency of amino acid substitutions in HBV/RT in the viral quasi species pool from LMV-failed (n = 16) and treatment-naïve (n = 14) CHB patients.

From: HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy

Amino acid substitutions in HBV/RT

Frequency (%) in HBV clonal population in LMV-failed CHB patients (total no of clones = 160)

Frequency (%) in HBV clonal population in treatment naïve-CHB patients (total no of clones = 140)

p-value (unadjusted)

Benjamini- Hochberg threshold

rtM204V

Known LMV- resistant mutations

26.3

0

2.05E-13*

0.000363

rtM204I

15.6

0

1.12E-07*

0.001962

rtS202G

17.5

0

1.12E-08*

0.00116

rtL80I

15.6

0

1.12E-07*

0.001962

rtL180M

26.3

0

2.05E-13*

0.000363

rtN53D

Novel amino acid substitutions

39.4

20

3.00E-04*

0.002326

rtY54H

43.1

27.1

5.30E-03

0.002616

rtL91I

8.8

0

1.00E-04*

0.00218

rtI121L

24.4

0

2.19E-12*

0.000436

rtF/H122L

42.5

14.3

6.56E-08*

0.001599

rtH124N

48.8

12.9

1.88E-11*

0.000727

rtQ130P

41.9

11.4

2.86E-09*

0.001017

rtN131D

50.6

15.7

1.27E-10*

0.000872

rtA219S

94.4

82.1

9.00E-04*

0.002471

rtH248N

78.8

56.4

4.00E-05*

0.002035

rtS256C

89.4

80.7

4.88E-2

0.002762

rtR266I

90.6

64.3

4.39E-08*

0.001453

rtH/L267Q

92.5

67.1

2.48E-08*

0.001308

rtV278I

50

12.9

4.06E-12*

0.000581

  1. *Significant after Benjamini-Hochberg correction; HBV/rt variants with significantly different frequency distribution after Benjamini-Hochberg correction are shown in bold.